VRPX
Virpax Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Next report
Analyst consensus
- Next report date
- Nov 19, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Mar 3, 2025
- EPS actual
- -$0.80
- EPS estimate
- -$0.27
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -12773.6%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Mar 3, 2025 | -$0.27 | -$0.80 | Miss -196.30% | — |
| Nov 14, 2024 | -$0.54 | -$11 | Miss -1890.74% | — |
| Nov 15, 2023 | -$0.26 | -$128 | Miss -48938.46% | — |
| Aug 14, 2023 | -$40 | -$68 | Miss -68.75% | — |
| May 12, 2023 | -$75 | -$33 | Beat 56.67% | — |
| Mar 22, 2023 | -$6.70 | -$65 | Miss -870.15% | — |
| Aug 15, 2022 | -$0.44 | -$125 | Miss -28309.09% | — |
| May 16, 2022 | — | -$110 | — | — |
| Mar 31, 2022 | -$3.40 | -$0.62 | Beat 81.86% | — |
| Nov 15, 2021 | — | -$133 | — | — |
| Aug 10, 2021 | — | -$118 | — | — |
| May 17, 2021 | -$0.54 | -$0.60 | Miss -11.68% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 19, 2026